Besides lowering cholesterol, statins exert multiple effects, such as anti-inflammatory activity and improvement of endothelial cell function. We examined whether simvastatin (SS) protects against the development of elastase-induced pulmonary emphysema in mice using mean linear intercepts of alveoli (Lm) as a morphometric parameter of emphysema. After injection of intratracheal elastase on day 0, C57BL/6 mice were treated daily with SS (SS+ group) or PBS (SS-group) for 2 weeks. A 21% decrease in Lm on day 7 was observed in SS+ compared with SS-group. Anti-inflammatory effects of SS were observed as a decrease in % neutrophils up to day 3, and in hydroxyproline pulmonary vessels tended to be higher in SS+ than in SS-group in this protocol.
Introduction signaling proteins, for example the GTP-binding proteins Rho and Rac (34), and can counteract the development of pulmonary emphysema (18) .
Several growth factors, such as G-CSF and hepatocyte growth factor (HGF), have healing effects on emphysematous lungs in animals (16, 23 ).
Ishizawa et al. found that HGF regenerated emphysematous changes by inducing angiogenesis in injured murine lungs by mobilizing EPCs (16) . Statins, like VEGF, G-CSF, and GM-CSF, mobilize EPCs from the bone marrow to peripheral blood (3, 30, 36) . Lee et al. have shown that statins also attenuated the emphysema induced by smoking in rats, mainly by their anti-inflammatory effects (18) . In the present study, we intended to treat elastase-induced emphysema in mice with simvastatin (SS), since it is hypothesized that statins may reverse emphysema through promoting alveolar cell proliferation in addition to their anti-inflammatory properties.
Materials and methods
Reagents and materials SS was purchased from Calbiochem (La Jolla, CA). Porcine pancreas elastase (PPE) was obtained from Sigma (St. Louis, MO). The mice used in all experiments were 8-week-old male C57BL/6, weighing approximately 20 g (Oriental Yeast, Tokyo, Japan). Human recombinant HGF was provided by Mitsubishi Pharma Co.
(Yokohama, Japan). All animals were humanely cared for, and the study was approved by the Keio University Panel on Laboratory Animal Care.
saline. The broncho-alveolar lavage fluid (BALF) was collected with a 1-ml syringe and placed on ice. The cells were counted with a hemocytometer. Cell differentials were counted on smears prepared by cytospin and stained with Diff-Quik (Kokusaishiyaku, Kobe, Japan). After centrifugation at 400 g for 5 min at 4HC, the concentrations of tumor necrosis factor (TNF)-, macrophage-inflammatory protein (MIP)-2, KC, and VEGF in the supernatants were measured, using ELISA kits (R&D systems, Minneapolis, MN). The lavage fluid was lyophilized and hydrolyzed in 2 ml of 6 M hydrocholic acid for 48 h at 110H C, and parts of the hydrolysate were used for measuring concentrations of desmosine and hydroxyproline. Plasma VEGF concentrations were also measured by ELISA. The sensitivity of the ELISA kits were 5.1 pg/ml for TNF-, 1.5 pg/ml for MIP-2, 2.0 pg/ml for KC, and 3.0 pg/ml for VEGF.
Immunohistochemical staining for proliferating cell nuclear antigen
The lung sections were incubated with a proliferating cell nuclear antigen Late phase protocol
The mice received 20ዊg of PPE in 50ዊl of saline or 50ዊl of saline alone by intratracheal instillation, at time zero, using the procedures described earlier. Fluorescence values for eNOS were normalized to those of a housekeeping gene, GAPDH, and expressed as fold-change over the CTL group.
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Statistical analysis
All data are presented as means±SD in Tables 1, 2 and Figures 1 Figure 2C 
Reduced recruitment of neutrophils into the airspaces by simvastatin
The percentage of neutrophils in BALF was significantly increased during the acute inflammatory phase, i.e., 2 h to 3 days after the instillation of PPE, and tended to be lower in the SS+ group than in the SS-group (Table 1) . However, this tendency was not observed in later time points during day 7-14 when the neutrophil percentages were less than 3% ( Table 1 ). The total cell count was similar in both groups at each time point (data not shown). 
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Changes in BALF concentrations of TNF-, MIP-2, and KC by simvastatin Despite its inhibitory effects on the accumulation of neutrophils, treatment with SS was associated with a significant increase in concentrations of TNF-and MIP-2 in BALF 2h after the instillation of PPE (Table 1) . However, BALF concentrations of TNF-and MIP-2 were both lower on day 1 in the SS+ group than in the SS-group. In contrast BALF concentrations of KC, another potent neutrophil neutrophil chemoattractant in mice, tended to decrease in the SS+ group compared with the SS-group throughout the acute phase (2h to day 7).
The number, median value and range (pg/ml) are presented as follows; In the acute phase, mean concentrations of BALF VEGF in the SS+ appeared to be higher than the SS-group but there was no significant difference ( Table 1 ).
The plasma concentrations were unchanged by treatment with SS in this protocol.
SS tended to increase VEGF concentrations in BALF in the late phase protocol (P=0.07, Table 2 ). In contrast VEGF concentrations in plasma were decreased by instillation of PPE in this protocol (P<0.05, SS-vs. CTL, Figure 6 ). In contrast eNOS mRNA expression in the lungs was increased in the SS-, SS+, and HGF groups, in which PPE was instilled, as compared with the CTL (P<0.01, Table 2 ).
Discussion
Elastase-induced emphysema is a simple model to study the development of emphysema over a couple of weeks (23). Neutrophilic inflammation may contribute to the morphometric change. In addition this model is particularly useful for evaluating regeneration when drugs were administered after the development of emphysema (15, 16) . Therefore we thought that this model was suitable for our purpose to investigate both aspects of SS effects, i.e.,
anti-inflammation and regeneration in the present study. We showed that SS, in presence of acute inflammation caused by PPE, partially protected against the development of pulmonary emphysema in mice. Anti-inflammatory effects as well as promotion of alveolar epithelial cell proliferation by SS were observed during the acute inflammatory phase. In contrast, Lm was markedly decreased when the administration of SS began 3 weeks after the instillation of elastase. At that time,
PCNA-positive cells were few in the SS-group, though were significantly increased by SS. In the late phase protocol, the acute inflammation had already resolved since we observed few neutrophils accumulation in the airways 14 days after the instillation ( Table 1 ). The effects of SS on the recovery from emphysema seemed greater than those exerted by HGF (Fig. 1B) Thus, VEGF might promote the proliferation of alveolar epithelial cells, indirectly as well as directly, in a tissue specific manner. In addition eNOS protein expression in the endothelial cells of pulmonary vessels was preserved by SS, supporting the notion that SS contributed to the reversal of emphysema through restoring endothelial cell functions. eNOS mRNA levels were not increased in the SS+ group compared with the SS-group. However, they were significantly increased in the SS-, SS+, and HGF groups compared with the CTL group in which eNOS protein expression was intact without increase in its mRNA level (Table 2) . We speculate that pulmonary vasculature in elastase-treated groups,
i.e., the SS-, SS+, and HGF groups, was similarly damaged by PPE, and SS increased eNOS mRNA levels, as previously reported (18) The number of mice, median value and range (µm or %) in each Values are mean±SD. #p<0.1, *p<0.05, **p<0.01, ***p<0.001 vs. SS(-). NE=not examined.
Hydroxyproline and Desmosine levels were measured on day 16 (not on day 14). 
